Outcome of Transurethral Plasmakinetic Vaporization for Benign Prostatic Hyperplasia
Purpose To assess the outcome of transurethral plasmakinetic vaporization (PKVP) in the management of benign prostatic hyperplasia (BPH). Patients and methods From August 2010 to May 2012, 60 patients with obstructive LUTS due to BPH were included in the study. All patients were evaluated by Interna...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Sociedade Brasileira de Urologia
2015-04-01
|
| Series: | International Brazilian Journal of Urology |
| Subjects: | |
| Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382015000200239&lng=en&tlng=en |
| _version_ | 1811299592019378176 |
|---|---|
| author | Magdy El-Tabey Ahmed Abo-Taleb Ashraf Abdelal Mostafa Mahmod Khalil |
| author_facet | Magdy El-Tabey Ahmed Abo-Taleb Ashraf Abdelal Mostafa Mahmod Khalil |
| author_sort | Magdy El-Tabey |
| collection | DOAJ |
| description | Purpose To assess the outcome of transurethral plasmakinetic vaporization (PKVP) in the management of benign prostatic hyperplasia (BPH). Patients and methods From August 2010 to May 2012, 60 patients with obstructive LUTS due to BPH were included in the study. All patients were evaluated by International Prostate Symptom Score (IPSS), general examination, digital rectal examination, PSA, routine laboratory examinations, pelvi-abdominal ultrasound, trans-rectal ultrasound, and uroflowmetry. Patients with Qmax of <10 mL/sec., an IPSS of >8 and a prostate volume of >40 mL underwent transurethral PKVP. Results Mean age of the patients was 66.8±4.5 years. The mean times of the operation, post-operative bladder irrigation, and post-operative catheterization were 63.8±13.9 minutes, 15.2±5.7 hours, and 23.9±5.2 hours, respectively. At 3 months of follow-up, there were significant reductions in the mean IPSS from 23.4±3.5 to 9.2±3.7 (P=0.4), mean PSA from 3.03±2.2 ng/mL to 1.2±1.04 ng/mL (P value=0.02), mean post voiding residual urine from 149.8±59.5 mL to 46.9±24.1 mL (P value <0.01), and mean prostate volume from 72.8±10.3 mL to 22.7±6.1 mL (P value <0.01). Also, there was a statistically significant increase in the mean Q max. from 8.7±2.4 mL/s to 19.5±3.5 mL/s (P value <0.01). Conclusion PKVP is an effective and safe treatment option in the management of symptomatic BPH. |
| first_indexed | 2024-04-13T06:39:04Z |
| format | Article |
| id | doaj.art-1136cba74b144bc1aa0f106fe253d5ad |
| institution | Directory Open Access Journal |
| issn | 1677-6119 |
| language | English |
| last_indexed | 2024-04-13T06:39:04Z |
| publishDate | 2015-04-01 |
| publisher | Sociedade Brasileira de Urologia |
| record_format | Article |
| series | International Brazilian Journal of Urology |
| spelling | doaj.art-1136cba74b144bc1aa0f106fe253d5ad2022-12-22T02:57:48ZengSociedade Brasileira de UrologiaInternational Brazilian Journal of Urology1677-61192015-04-0141223924410.1590/S1677-5538.IBJU.2015.02.08S1677-55382015000200239Outcome of Transurethral Plasmakinetic Vaporization for Benign Prostatic HyperplasiaMagdy El-TabeyAhmed Abo-TalebAshraf AbdelalMostafa Mahmod KhalilPurpose To assess the outcome of transurethral plasmakinetic vaporization (PKVP) in the management of benign prostatic hyperplasia (BPH). Patients and methods From August 2010 to May 2012, 60 patients with obstructive LUTS due to BPH were included in the study. All patients were evaluated by International Prostate Symptom Score (IPSS), general examination, digital rectal examination, PSA, routine laboratory examinations, pelvi-abdominal ultrasound, trans-rectal ultrasound, and uroflowmetry. Patients with Qmax of <10 mL/sec., an IPSS of >8 and a prostate volume of >40 mL underwent transurethral PKVP. Results Mean age of the patients was 66.8±4.5 years. The mean times of the operation, post-operative bladder irrigation, and post-operative catheterization were 63.8±13.9 minutes, 15.2±5.7 hours, and 23.9±5.2 hours, respectively. At 3 months of follow-up, there were significant reductions in the mean IPSS from 23.4±3.5 to 9.2±3.7 (P=0.4), mean PSA from 3.03±2.2 ng/mL to 1.2±1.04 ng/mL (P value=0.02), mean post voiding residual urine from 149.8±59.5 mL to 46.9±24.1 mL (P value <0.01), and mean prostate volume from 72.8±10.3 mL to 22.7±6.1 mL (P value <0.01). Also, there was a statistically significant increase in the mean Q max. from 8.7±2.4 mL/s to 19.5±3.5 mL/s (P value <0.01). Conclusion PKVP is an effective and safe treatment option in the management of symptomatic BPH.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382015000200239&lng=en&tlng=enProstatic HyperplasiaTransurethral Resection of ProstateProstatectomy |
| spellingShingle | Magdy El-Tabey Ahmed Abo-Taleb Ashraf Abdelal Mostafa Mahmod Khalil Outcome of Transurethral Plasmakinetic Vaporization for Benign Prostatic Hyperplasia International Brazilian Journal of Urology Prostatic Hyperplasia Transurethral Resection of Prostate Prostatectomy |
| title | Outcome of Transurethral Plasmakinetic Vaporization for Benign Prostatic Hyperplasia |
| title_full | Outcome of Transurethral Plasmakinetic Vaporization for Benign Prostatic Hyperplasia |
| title_fullStr | Outcome of Transurethral Plasmakinetic Vaporization for Benign Prostatic Hyperplasia |
| title_full_unstemmed | Outcome of Transurethral Plasmakinetic Vaporization for Benign Prostatic Hyperplasia |
| title_short | Outcome of Transurethral Plasmakinetic Vaporization for Benign Prostatic Hyperplasia |
| title_sort | outcome of transurethral plasmakinetic vaporization for benign prostatic hyperplasia |
| topic | Prostatic Hyperplasia Transurethral Resection of Prostate Prostatectomy |
| url | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382015000200239&lng=en&tlng=en |
| work_keys_str_mv | AT magdyeltabey outcomeoftransurethralplasmakineticvaporizationforbenignprostatichyperplasia AT ahmedabotaleb outcomeoftransurethralplasmakineticvaporizationforbenignprostatichyperplasia AT ashrafabdelal outcomeoftransurethralplasmakineticvaporizationforbenignprostatichyperplasia AT mostafamahmodkhalil outcomeoftransurethralplasmakineticvaporizationforbenignprostatichyperplasia |